Ciluprevir

N/A

Report date: 2026/03/23 20:03:44
NME

Base Information

Drug NameCiluprevir
Drug Alias Name西鲁瑞韦ciluprevirumBILN-2061BILN-2061-ZW
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis C virus (HCV) nonstructural protein 3 inhibitors
TargetsHepatitis C virus (HCV) nonstructural protein 3
Therapy Area/IndicationsLiver CirrhosisHepatitis C, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesC.H. Boehringer Sohn Ag & Co. Kg
Active IndicationsN/A
Inactive IndicationsLiver CirrhosisHepatitis C, Chronic

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG